Paper Details

  1. Home
  2. Paper Details

Multiple-Dose Intravenous Tranexamic Acid Further Reduces Hidden Blood Loss After Total Hip Arthroplasty: A Randomized Controlled Trial.

Author: ChenGuo, HuangQiang, HuangZeyu, LeiYiting, PeiFuxing, XieJinwei

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A 5-dose intravenous tranexamic acid regimen was found to further diminish hidden blood loss, decrease maximum hemoglobin drop, provide additional fibrinolysis control, and ameliorate postoperative inflammatory response following total hip arthroplasty.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The most appropriate dose of tranexamic acid in total hip arthroplasty (THA) has not been decided. This study was conducted to evaluate the clinical effects of multiple-dose intravenous tranexamic acid (IV-TXA) in THA. METHODS: One hundred fifty patients were randomized to receive one d...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.arth.2018.04.024

データ提供：米国国立医学図書館（NLM）

Multiple-Dose Tranexamic Acid: A Camel's Guide to Minimizing Blood Loss After Hip Surgery

Imagine a camel undergoing a major surgery in the desert, facing the potential for significant blood loss. Just as a camel's body has mechanisms to minimize bleeding, this study investigates the role of tranexamic acid (TXA) in reducing blood loss after total hip arthroplasty (THA). Researchers evaluated the effectiveness of multiple doses of intravenous TXA, comparing different regimens on 150 patients. The results showed that the 5-dose regimen significantly reduced hidden blood loss, total blood loss, and maximum hemoglobin drop compared to lower-dose regimens. This study, like a camel's protective armor, provides insights into how to minimize blood loss and optimize recovery after THA.

Multiple-Dose TXA: A Blood-Saving Strategy After Hip Surgery

The study demonstrates the effectiveness of multiple-dose IV-TXA in reducing blood loss after THA. These findings offer a valuable strategy for surgeons seeking to minimize blood loss and improve patient outcomes. It's like equipping the camel with a special shield to protect it from unnecessary blood loss during its journey back to health.

What Does This Mean for Our Health?

The use of multiple-dose IV-TXA could lead to improved recovery after THA, minimizing blood loss and potentially reducing the need for blood transfusions. This approach can help patients experience a smoother and more comfortable recovery, allowing them to get back on their feet more quickly. It's like providing the camel with a well-stocked oasis, ensuring a swift and successful journey back to health after its surgical ordeal.

Dr. Camel's Conclusion

The desert of surgical procedures is full of challenges. This study provides valuable insights into the role of TXA in minimizing blood loss after THA. The findings suggest that a 5-dose regimen could significantly improve patient outcomes. This research serves as a valuable guide for surgeons seeking to optimize care for their patients.

Date :
  1. Date Completed 2019-03-08
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

29759857

DOI: Digital Object Identifier

10.1016/j.arth.2018.04.024

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.